| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-induced apoptosis, in
several systems. We therefore investigated whether the injection of a
caspase inhibitor prevents LPS-induced apoptosis and acute lung injury
in mice. LPS (30 mg/kg) was administered intravenously to Institute for
Cancer Research mice. Electron microscopic findings demonstrated
characteristic features of apoptosis in endothelial cells and alveolar
epithelial cells. The caspase-3 activity and the number of terminal
dUTP nick-end labeling-positive cells in lung tissues were
significantly increased after LPS administration.
Benzyloxycarbonil-Val-Ala-Asp fluoromethylketone
(Z-VAD.fmk), which is a broad-spectrum caspase
inhibitor, was injected before and after the administration of
LPS. The injection of Z-VAD.fmk suppressed the caspase-3 activity in
lung tissues, and significantly decreased the number of
terminal dUTP nick-end labeling-positive cells. Furthermore,
the survival rate of mice was prolonged significantly by the
injection of Z-VAD.fmk. These results indicate that apoptosis may play
an important role in acute lung injury, and thus that
inhibition of caspase activity may constitute a new therapeutic
approach for treatment of this disease.
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The alveolar epithelium is a key structural component for gas exchange in the lung. In addition, alveolar epithelial cells synthesize, secrete, and take up the surfactant, which is a key determinant of intra-alveolar pressure. The predominant pathological finding in acute lung injury is diffuse alveolar damage.8 The severity of lung injury is closely associated with the structural and functional deficiency of epithelial cells.9,10 Therefore, treatments aimed at diminishing the damage to epithelial cells might become a key element in accelerating recovery and decreasing the mortality of patients with lung injury.11
Lipopolysacharride (LPS) is one of the major factors that induce acute
lung injury. Recently, it was reported that injection of LPS induced
disseminated endothelial apoptosis, preceding nonendothelial tissue
damage in mice,12,13
and that tumor necrosis factor-
and ceramide generation indicated LPS-induced endothelial cell
apoptosis. Guinee et al14
reported that apoptosis of
epithelial cells was detected in diffuse alveolar damage. It was also
recently reported that apoptosis of epithelial cells and the Fas/Fas
ligand system plays an important role in the pathogenesis of acute
respiratory distress syndrome.15
Furthermore, apoptosis of
parenchymal cells might trigger widespread organ
inflammation.16-18
Activation of caspases is one of the intracellular events required for
cell death, including tumor necrosis factor--induced
apoptosis,.19
The tripeptide benzyloxycarbonil-Val-Ala-Asp
fluoromethylketone (Z-VAD.fmk), a broad-spectrum caspase inhibitor, has
been shown to inhibit the intracellular activation of caspase-like
proteases in vitro.20
Because apoptosis of
endothelial and epithelial cells in lung tissues is an important event
in acute lung injury, caspase inhibitors could be a novel therapy for
this disease via protection of the parenchymal cells.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Mice used in this study were 5- to 6-week-old (20 to 22 g) ICR males (Kyudo, Tosu, Japan). Mice were injected with 30 mg/kg LPS from E. coli serotype O111:B4 (Difco Laboratories, Detroit, MI) through the tail vein. Z-VAD.fmk (Kamiya, Thousand Oaks, CA) was dissolved at 2 mg/ml in 1% dimethyl sulfoxide in sterile saline, and administered to mice by the method of Rodriguez et al.21 A single intravenous injection of Z-VAD.fmk (0.25 mg) was made 15 minutes before LPS injection, followed by three intravenous injections of Z-VAD.fmk (0.1 mg each) per hour. Control mice were injected with the same volume of 1% DMSO in sterile saline.
Histological Examination
The mice were killed by exsanguination at 3, 6, 12, or 24 hours after the administration of LPS. After thoracotomy, the pulmonary circulation was flushed with saline, and the lungs were explored. After sacrifice, lung samples were inflated with 10% formalin solution instilled at 15 cm H2O pressure through the trachea for 2 hours and fixed with buffered 10% formalin solution for 24 hours. After embedding in paraffin, samples were cut at 5-µm thickness and stained with hematoxylin and eosin (H&E).
For electron microscopy, LPS-treated mice were killed 24 hours after LPS injection, and lungs were fixed with 2.5% glutaldehyde in 0.1 mol/L phosphate buffer, pH 7.4, for 18 hours. The lungs were dissected into small pieces and postfixed for 1.5 hours in 1% OsO4 dissolved in 0.1 mol/L phosphate buffer (pH 7.4), then dehydrated through a series of graded ethanol solutions and embedded in Epon. Ultrathin sections were cut, stained with uranyl acetate and lead nitrate, and examined under a JEM-1200 EX transmission electron microscope (Jeol, Tokyo, Japan).
Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick End-Labeling (TUNEL) Assay
Apoptosis in vivo was assessed by TUNEL. The lungs were fixed overnight at 4°C in 10% buffered formalin, and were embedded in paraffin. An in situ Apoptosis Detection Kit (Takara, Otau, Japan) was used to carry out TUNEL staining on sections of 5-µm thickness according to the manufacturer’s instructions.22 Color revelation was realized with diaminobenzidine. Ten fields at x200 were randomly selected, and the number of TUNEL-positive cells was calculated.
Caspase Activity Analysis
The activity of caspase-1 and caspase-3 were determined using a fluorometric CaspACE Assay System (Promega, Madison, WI). In brief, lung protein extracts were prepared by the homogenization of frozen lung tissues in a hypotonic buffer (25 mmol/L Hepes, pH 7.5, 5 mmol/L MgCl2, 1 mmol/L ethylen bis(oxyethylenenitrile)-tetraacetic acid (EGTA), 1 mmol/L phenylmethyl sulfonyl fluoride, 1 mg/ml leupeptin, and aprotinin). Homogenates were centrifuged (15,000 rpm, 10 minutes, 4°C), and the supernatants were used. Twenty µg of the extracted proteins were incubated with the fluorescent substrates YVAD-AMC (Ac-Tyr-Val-Ala-Asp-aminomethylcoumarin) for caspase-1 or DEVD-AMC (Ac-Asp-Gul-Val-Asp-amino-methylcoumarin) for caspase-3. The fluorescence of cleaved substrates was determined using a spectrofluorometer at an excitation wavelength of 360 nm and an emission wavelength of 460 nm. The caspase activity was expressed in picomoles per minute per milligram of protein.
Measurement of Myeloperoxidase (MPO) Activity
The lung tissue MPO activity was determined following a previously described method23 with minor modifications. The lungs were removed from the thorax, blotted with gauze to remove blood, and frozen at -80°C until assay. Collected lungs were then homogenized for 30 seconds at 4°C in 1 ml phosphate-buffered saline (PBS). The corresponding extracts were centrifuged (15,000 rpm, 10 minutes, 4°C), and supernatants containing hemoglobin were discarded. The pellets were resuspended in 1 ml PBS supplemented with hexodecyl-trimethyl-ammonium bromide (HTAB, 0.5%) and ethylenediaminetetraacetic acid (5 mmol/L) and homogenized again. After centrifugation, 50 µl of each supernatant was placed in a test tube with 200 µl of PBS-HTAB-ethylenediaminetetraacetic acid, 2 ml PBS, 100 µl O-dianisidine dihydrochloride (1.25 mg/ml), and 100 µl H2O2 (0.4 mmol/L). The MPO activity was determined as the change in absorbance at 460 nm for 15 minutes.
Serum Interleukin (IL)-1ß Levels
The concentration of IL-1ß in the serum was measured using a mouse IL-1ß enzyme-linked immunosorbent assay kit (Biosource International, Camarillo, CA) according to the manufacturer’s protocol.
Statistical Analysis
Statistical analysis was performed by Student’s t-test. Survival curves (Kaplan-Meier plots) were compared using a log rank test. A P value <0.05 was considered statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
H&E staining of lung tissue from LPS-treated mice revealed
thickening of the alveolar septa and infiltration of inflammatory cells
at 24 hours after LPS injection (Figure 1A)
. The inflammatory cells in lung
tissues consisted of a large number of neutrophils and some
lymphocytes. These findings were consistent with those of other
investigators.24,25
Positive signals for TUNEL were found
at 41.8 ± 9.8/x200 field in lung tissues 24 hours after LPS
administration (Figure 1C)
. The number of TUNEL-positive cells was
significantly (P < 0.01) and time-dependently
increased after LPS administration (Figure 2)
. Electron microscopy on lung tissues
isolated from mice at 24 hours after LPS administration demonstrated
the condensation of chromatin and the cell shrinkage in type I and II
alveolar epithelial cells, and large vacuoles in endothelial cells
(Figure 3)
. These findings were
consistent with the characteristic features of apoptosis.
|
|
|
Z-VAD.fmk treatment did not affect the pathological findings on
H&E staining at 24 hours of LPS-induced lung injury (Figure 1B)
. To
access the neutrophil sequestration in lung tissues, we investigated
the MPO activity in lung tissues. The MPO activity in lung tissues 24
hours after LPS administration was about eight times higher than that
in control mice (control, 1.9 ± 1.2; LPS, 15.9 ± 2.2
OD460/gram of lung). Z-VAD.fmk did not affect the MPO activity in
lung tissues (LPS + Z-VAD.fmk, 13.1 ± 0.3; P =
0.19 compared with LPS alone). We also examined the lung weight/body
weight ratio. Although the ratio was significantly elevated from 6
hours to 24 hours after LPS administration, Z-VAD.fmk treatment did not
affect the lung weight/body weight ratio. However, the Z-VAD.fmk
treatment significantly decreased the number of TUNEL-positive cells
from 12 to 24 hours after LPS administration (LPS and LPS plus
Z-VAD.fmk-treated mice at 12 hours, 1.8 ± 0.4 and 0.1 ±
0.3; at 24 hours, 41.8 ± 9.8 and 12.0 ± 2.2/x200 field,
respectively) (Figures 1D and 2)
.
The Caspase-1 and Caspase-3 Activity in Lung Tissues
Accumulating evidence indicates that the activation of
caspases is critical for many forms of apoptotic cell death. We
examined whether the caspase activity was increased after LPS
administration. Lung extracts were incubated with the tetrapeptide
substrates YVAD-AMC or DEVD-AMC. YVAD-AMC is a preferred substrate for
caspase-1 and DEVD-AMC is a preferred substrate for caspase-3. Figure 4
demonstrates the change of caspase-1
and caspase-3 activity in lung tissues. The enzyme activity was assayed
spectrophotometrically by measuring the extent of cleavage of the
peptide substrate by the extracts. Although no change was observed in
caspase-1 activity, caspase-3 activity was significantly increased in a
time-dependent manner. The caspase-3 activity was about fourfold that
of controls at 12 hours, and 10-fold that of controls at 24 hours after
LPS administration. The Z-VAD.fmk treatment suppressed caspase-3
activity in lung tissues from 6 hours to 24 hours after LPS
administration (LPS and LPS plus Z-VAD.fmk-treated mice at 6 hours,
1703 ± 399 and 941 ± 218, P = 0.07; at 12
hours, 3533 ± 476 and 1392 ± 207, P = 0.02;
at 24 hours: 7601 ± 1472 and 5382 ± 819, P
= 0.18, respectively, unit: pmol/minutes/mg protein).
|
To determine the effect of Z-VAD.fmk on caspase activation of
pro-IL-1ß, we measured the concentration of IL-1ß in serum (Table 1)
. The concentration of IL-1ß in serum
from mice injected with LPS was increased from 6 to 24 hours. The
Z-VAD.fmk treatment did not affect the elevation of serum IL-1ß
levels.
|
Survival data are presented in Figure 5
. All mice succumbed to LPS within 30
hours. By contrast, the mice treated with Z-VAD.fmk survived
significantly (P < 0.05) longer and 27% of the
mice survived more than 7 days. Histological examination of the lungs
of mice surviving at 7 days revealed normal lung architecture (data not
shown).
|
We also examined liver tissues, because LPS might induce other organ failure. LPS neither induced inflammatory changes nor increased the number of TUNEL-positive cells in the liver. In addition, caspase activity in liver tissues was not affected by the administration of LPS with or without Z-VAD.fmk (data not shown).
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Initially, Z-VAD.fmk was used as an inhibitor of caspase-1 (ICE: IL-1ß converting enzyme)-like activity in vitro.20 More recently, Z-VAD.fmk was reported to suppress broad-spectrum caspases, particularly in an in vivo model. Further, it has been reported that Z-VAD.fmk inhibits the caspase-3-like activity more than the caspase-1-like activity.16 A recent study has revealed two main pathways of caspase activation.19 In the first pathway, the activation of initiator caspase-8 is triggered by the ligation of death receptors, including Fas and tumor necrosis factor type I receptors. In the second pathway, a variety of extracellular and intracellular death stimuli trigger the release of cytochrome c from mitochondria. Cytosolic cytochrome c binds to Apaf-1 (apoptotic protease activating factor 1), and Apaf-1 promotes the activation of caspase-9. Active caspase-8 or caspase-9 activates the effector caspase-3. The active caspase-3 mediates the cleavage of apoptotic regulators, resulting in morphological features of apoptosis and demise of the cell. We have shown here that the caspase-3 activity and the number of TUNEL-positive cells in the lung dramatically increased in an LPS-induced acute lung injury model. Administration of Z-VAD.fmk in vivo inhibited the caspase-3 activity and prevented LPS-mediated apoptosis. Because Z-VAD.fmk inhibits the activation of caspase-3, it can prevent both pathways of caspase-mediated apoptosis. Therefore, it is considered that Z-VAD.fmk could prevent death-receptor mediated apoptosis and another apoptosis pathway triggered by a variety of stimuli, such as inflammatory cytokines, growth factors, reactive oxygen, and others, which are also involved in this model.
Caspase-1 is considered not to be important in apoptotic processes, but to be the key factor in generating the bioactive form of the proinflammatory cytokine IL-1ß from its biologically inactive precursor.30 In contrast to caspase-3, no increase in caspase-1 activity was observed in the lung tissues of LPS-administered mice, in the present study. An increase of caspase-3 activity without any change of caspase-1 activity has also been observed in LPS-stimulated liver tissues in D-galactosamine-sensitized mice.16,31 Although caspase-1 activity was not increased in lung tissues, IL-1ß concentration in the serum was increased after LPS administration. Furthermore, this increase was not suppressed by Z-VAD.fmk. It has been reported that ICE-deficient mice can still generate mature IL-1ß in response to local inflammatory stimulation.32 Recently, it was also suggested that IL-1ß could be activated by other proteases, such as other caspases, matrix metalloproteinases, and proteinase 3.33-35 Therefore, it is considered that IL-1ß can be released in vivo in a caspase-1-independent manner without affecting Z-VAD.fmk. The lack of a significant increase of caspase-1 activity under this condition was attributed to the fact that the protective effect of Z-VAD.fmk on LPS-induced apoptosis of endothelial cells and epithelial cells was mainly mediated by the inhibition of caspase-3 activity.
Apoptosis of neutrophils is generally considered to be important in the resolution of inflammation.36 Apoptosis provides a way to remove neutrophils from an area of inflammation with minimal damage to the surrounding tissue. It has been reported that bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome prolongs the survival of normal human neutrophils in vitro.37 Initially, we expected that Z-VAD.fmk might suppress the neutrophil apoptosis, leading to the observed accumulation of neutrophils in the lung tissue. However, the number of accumulated neutrophils in lung tissues was not increased by Z-VAD.fmk treatment. Although the serum IL-1ß level was not decreased by Z-VAD.fmk administration, Z-VAD.fmk inhibited epithelial and endothelial cell apoptosis without any effect on the number of neutrophils in lung tissues. It is possible that apoptosis of epithelial and endothelial cells is primarily dependent on the caspase cascade, whereas neutrophil apoptosis is not.38 Another possibility is that Z-VAD.fmk suppresses the sequestration of neutrophils, because of decreased parenchymal cell damage, and also suppresses the apoptosis of those neutrophils that lived longer. Although we did not address the mechanism by which Z-VAD.fmk affects the function of neutrophils in acute lung injury in this study, it is considered to be important for the treatment of acute lung injury that Z-VAD.fmk does not augment neutrophil accumulation.
In a previous study using the present model, it was reported that injection of LPS induced disseminated endothelial apoptosis in the intestine, lung, fat tissue, and thymus.12 We also reported that apoptosis of endothelial cells occurred in LPS-induced lung injury in mice.13 In the present study, we evaluated the lung and liver tissue, because they were considered to be very important organs in sepsis. As there were no histological changes or apoptosis in the liver, apoptosis in the lung tissue was considered to be critical in this model.
In summary, we have shown that apoptotic cells and caspase-3 activity were significantly increased in the lung tissues of mice sustaining LPS-induced lung injury. Electron microscopic findings demonstrated the morphological characteristics of apoptosis on the pulmonary endothelial and epithelial cells. Apoptosis of these cells was considered to be important in lung injury because of the loss of normal functional cells. The injection of Z-VAD.fmk decreased the caspase-3 activity and the number of TUNEL-positive cells, and also improved the survival of mice. Because the survival of mice was only improved from 0 to 27% by Z-VAD.fmk treatment, it is possible that the dose of caspase inhibitor was insufficient or that factors other than apoptosis affected the survival of mice in this model. However, our results indicate that apoptosis of lung parenchymal cells may play an important role in the pathophysiology of lung injury, and that inhibition of caspase activity could be a new therapeutic approach against lung injury. As the murine endotoxin model is not always an accurate indication of responses in humans, the study might need to be repeated with a tissue model of infection.
|
Footnotes |
|---|
Supported by a Grant-in-Aid for Scientific Research (10770266) from the Ministry of Education, Science and Culture of Japan.
Accepted for publication May 19, 2000.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998, 160:3480-3486 and ligation of Fas antigen. J Immunol 1995, 155:4147-4154[Abstract]
-((2,6-dichlorobenzoyl)oxy)methyl ketones as potent time-dependent inhibitors of interleukin-1ß-converting enzyme. J Med Chem 1994, 37:563-564[Medline]
and IL-1ß from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA 1999, 96:6261-6266This article has been cited by other articles:
 |
|
 |
|
  R. L. Zemans, S. P. Colgan, and G. P. Downey Transepithelial Migration of Neutrophils: Mechanisms and Implications for Acute Lung Injury Am. J. Respir. Cell Mol. Biol., May 1, 2009; 40(5): 519 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Bem, J. B. M. van Woensel, A. P. Bos, A. Koski, A. W. Farnand, J. B. Domachowske, H. F. Rosenberg, T. R. Martin, and G. Matute-Bello Mechanical ventilation enhances lung inflammation and caspase activity in a model of mouse pneumovirus infection Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L46 - L56. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matute-Bello, C. W. Frevert, and T. R. Martin Animal models of acute lung injury Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L379 - L399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Damico, A. Chesley, L. Johnston, E. P. Bind, E. Amaro, J. Nijmeh, B. Karakas, L. Welsh, D. B. Pearse, J. G. N. Garcia, et al. Macrophage Migration Inhibitory Factor Governs Endothelial Cell Sensitivity to LPS-Induced Apoptosis Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Tang, M. Mura, R. Seth, and M. Liu Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L632 - L641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Guan, P. S. Nagarkatti, and M. Nagarkatti Blockade of Hyaluronan Inhibits IL-2-Induced Vascular Leak Syndrome and Maintains Effectiveness of IL-2 Treatment for Metastatic Melanoma J. Immunol., September 15, 2007; 179(6): 3715 - 3723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Wang, I. O. Akinci, C. M. Baker, D. Urich, A. Bellmeyer, M. Jain, N. S. Chandel, G. M. Mutlu, and G. R. S. Budinger The Intrinsic Apoptotic Pathway Is Required for Lipopolysaccharide-Induced Lung Endothelial Cell Death J. Immunol., August 1, 2007; 179(3): 1834 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-s. Cheng, W. Han, S. M. Chen, T. P. Sherrill, M. Chont, G.-Y. Park, J. R. Sheller, V. V. Polosukhin, J. W. Christman, F. E. Yull, et al. Airway Epithelium Controls Lung Inflammation and Injury through the NF-{kappa}B Pathway J. Immunol., May 15, 2007; 178(10): 6504 - 6513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Emamaullee, L. Stanton, C. Schur, and A.M. J. Shapiro Caspase Inhibitor Therapy Enhances Marginal Mass Islet Graft Survival and Preserves Long-Term Function in Islet Transplantation Diabetes, May 1, 2007; 56(5): 1289 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Alvira, A. Abate, G. Yang, P. A. Dennery, and M. Rabinovitch Nuclear Factor-{kappa}B Activation in Neonatal Mouse Lung Protects against Lipopolysaccharide-induced Inflammation Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 805 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Martin, N. Hagimoto, M. Nakamura, and G. Matute-Bello Apoptosis and Epithelial Injury in the Lungs Proceedings of the ATS, October 1, 2005; 2(3): 214 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Suzuki, T. J. Moraes, E. Vachon, H. H. Ginzberg, T.-T. Huang, M. A. Matthay, M. D. Hollenberg, J. Marshall, C. A. G. McCulloch, M. T. H. Abreu, et al. Proteinase-Activated Receptor-1 Mediates Elastase-Induced Apoptosis of Human Lung Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 231 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Wesche, J. L. Lomas-Neira, M. Perl, C.-S. Chung, and A. Ayala Leukocyte apoptosis and its significance in sepsis and shock J. Leukoc. Biol., August 1, 2005; 78(2): 325 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Vera, S. Rodriguez, M. Castanares, Y. Lue, V. Atienza, C. Wang, R. S. Swerdloff, and A. P. Sinha Hikim Functional Role of Caspases in Heat-Induced Testicular Germ Cell Apoptosis Biol Reprod, March 1, 2005; 72(3): 516 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Abadie, F. Bregeon, L. Papazian, F. Lange, B. Chailley-Heu, P. Thomas, P. Duvaldestin, S. Adnot, B. Maitre, and C. Delclaux Decreased VEGF concentration in lung tissue and vascular injury during ARDS Eur. Respir. J., January 1, 2005; 25(1): 139 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakagomi, O. Kitada, K. Kuribayashi, H. Yoshikawa, K. Ozawa, S. Ogawa, and T. Matsuyama The 150-Kilodalton Oxygen-Regulated Protein Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice Am. J. Pathol., October 1, 2004; 165(4): 1279 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Geiser, M. Ishigaki, C. van Leer, M. A. Matthay, and V. C. Broaddus H2O2 inhibits alveolar epithelial wound repair in vitro by induction of apoptosis Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L448 - L453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Rudkowski, E. Barreiro, R. Harfouche, P. Goldberg, O. Kishta, P. D'Orleans-Juste, J. Labonte, O. Lesur, and S. N. A. Hussain Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L793 - L800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Bannerman and S. E. Goldblum Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L899 - L914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Aird The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome Blood, May 15, 2003; 101(10): 3765 - 3777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Rowe, L. Allen, V. C. Ridger, P. G. Hellewell, and M. K. B. Whyte Caspase-1-Deficient Mice Have Delayed Neutrophil Apoptosis and a Prolonged Inflammatory Response to Lipopolysaccharide-Induced Acute Lung Injury J. Immunol., December 1, 2002; 169(11): 6401 - 6407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Erwert, R. K. Winn, J. M. Harlan, and D. D. Bannerman Shiga-like Toxin Inhibition of FLICE-like Inhibitory Protein Expression Sensitizes Endothelial Cells to Bacterial Lipopolysaccharide-induced Apoptosis J. Biol. Chem., October 18, 2002; 277(43): 40567 - 40574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hamacher, R. Lucas, H. R. Lijnen, S. Buschke, Y. Dunant, A. Wendel, G. E. Grau, P. M. Suter, and B. Ricou Tumor Necrosis Factor-{alpha} and Angiostatin Are Mediators of Endothelial Cytotoxicity in Bronchoalveolar Lavages of Patients with Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 651 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Tsi, Y. Chao, C.-W. Chen, and W. W. Lin Aurintricarboxylic Acid Protects against Cell Death Caused by Lipopolysaccharide in Macrophages by Decreasing Inducible Nitric-Oxide Synthase Induction via Ikappa B Kinase, Extracellular Signal-Regulated Kinase, and p38 Mitogen-Activated Protein Kinase Inhibition Mol. Pharmacol., July 1, 2002; 62(1): 90 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Bannerman, J. C. Tupper, R. D. Erwert, R. K. Winn, and J. M. Harlan Divergence of Bacterial Lipopolysaccharide Pro-apoptotic Signaling Downstream of IRAK-1 J. Biol. Chem., March 1, 2002; 277(10): 8048 - 8053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nau and H. Eiffert Modulation of Release of Proinflammatory Bacterial Compounds by Antibacterials: Potential Impact on Course of Inflammation and Outcome in Sepsis and Meningitis Clin. Microbiol. Rev., January 1, 2002; 15(1): 95 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tesfaigzi, K. Rudolph, M. J. Fischer, and C. A. Conn Bcl-2 mediates sex-specific differences in recovery of mice from LPS-induced signs of sickness independent of IL-6 J Appl Physiol, November 1, 2001; 91(5): 2182 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Matute-Bello, C. W. Frevert, W. C. Liles, M. Nakamura, J. T. Ruzinski, K. Ballman, V. A. Wong, C. Vathanaprida, and T. R. Martin Fas/Fas Ligand System Mediates Epithelial Injury, but Not Pulmonary Host Defenses, in Response to Inhaled Bacteria Infect. Immun., September 1, 2001; 69(9): 5768 - 5776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Leskinen, Y. Wang, D. Leszczynski, K. A. Lindstedt, and P. T. Kovanen Mast Cell Chymase Induces Apoptosis of Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 516 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Bannerman, J. C. Tupper, W. A. Ricketts, C. F. Bennett, R. K. Winn, and J. M. Harlan A Constitutive Cytoprotective Pathway Protects Endothelial Cells from Lipopolysaccharide-induced Apoptosis J. Biol. Chem., April 27, 2001; 276(18): 14924 - 14932. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
